BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19130741)

  • 1. Altered distribution of lamin and emerin in muscle nuclei of sIBM patients.
    Fidzianska A; Glinka Z; Kaminska A; Niebroj-Dobosz I
    Clin Neuropathol; 2008; 27(6):424-9. PubMed ID: 19130741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
    Greenberg SA; Pinkus JL; Amato AA
    Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients.
    Kierdaszuk B; Berdynski M; Palczewski P; Golebiowski M; Zekanowski C; Kaminska AM
    Folia Neuropathol; 2015; 53(4):355-66. PubMed ID: 26785370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H1 is released from myonuclei and present in rimmed vacuoles with DNA in inclusion body myositis.
    Nakano S; Shinde A; Fujita K; Ito H; Kusaka H
    Neuromuscul Disord; 2008 Jan; 18(1):27-33. PubMed ID: 17888663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of emerin and lamins in muscle of patients with different forms of Emery-Dreifuss muscular dystrophy.
    Niebroj-Dobosz I; Fidzianska A; Hausmanowa-Petrusewicz I
    Acta Myol; 2003 Sep; 22(2):52-7. PubMed ID: 14959564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
    Pinkus JL; Amato AA; Taylor JP; Greenberg SA
    Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colocalization of emerin and lamins in interphase nuclei and changes during mitosis.
    Manilal S; Nguyen TM; Morris GE
    Biochem Biophys Res Commun; 1998 Aug; 249(3):643-7. PubMed ID: 9731189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of emerin and lamins in the heart and implications for Emery-Dreifuss muscular dystrophy.
    Manilal S; Sewry CA; Pereboev A; Man N; Gobbi P; Hawkes S; Love DR; Morris GE
    Hum Mol Genet; 1999 Feb; 8(2):353-9. PubMed ID: 9949197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The apparent absence of lamin B1 and emerin in many tissue nuclei is due to epitope masking.
    Tunnah D; Sewry CA; Vaux D; Schirmer EC; Morris GE
    J Mol Histol; 2005 Jun; 36(5):337-44. PubMed ID: 16283426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between emerin and nuclear lamins.
    Sakaki M; Koike H; Takahashi N; Sasagawa N; Tomioka S; Arahata K; Ishiura S
    J Biochem; 2001 Feb; 129(2):321-7. PubMed ID: 11173535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
    Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
    Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
    Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
    Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The etiology and pathogenesis of sporadic inclusion body myositis].
    Murata KY; Ito H
    Brain Nerve; 2014 Nov; 66(11):1385-94. PubMed ID: 25407074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pathogenic mis-sense mutations in lamin A on its interaction with emerin in vivo.
    Holt I; Ostlund C; Stewart CL; Man Nt; Worman HJ; Morris GE
    J Cell Sci; 2003 Jul; 116(Pt 14):3027-35. PubMed ID: 12783988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesprin-2 is a multi-isomeric protein that binds lamin and emerin at the nuclear envelope and forms a subcellular network in skeletal muscle.
    Zhang Q; Ragnauth CD; Skepper JN; Worth NF; Warren DT; Roberts RG; Weissberg PL; Ellis JA; Shanahan CM
    J Cell Sci; 2005 Feb; 118(Pt 4):673-87. PubMed ID: 15671068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of sporadic inclusion body myositis in China.
    Li K; Pu C; Huang X; Liu J; Mao Y; Lu X
    Neurol Neurochir Pol; 2015; 49(4):245-50. PubMed ID: 26188941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.
    Bastian A; Goebel HH
    Rom J Intern Med; 2010; 48(4):377-84. PubMed ID: 21528768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The R482Q lamin A/C mutation that causes lipodystrophy does not prevent nuclear targeting of lamin A in adipocytes or its interaction with emerin.
    Holt I; Clements L; Manilal S; Brown SC; Morris GE
    Eur J Hum Genet; 2001 Mar; 9(3):204-8. PubMed ID: 11313760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerin-prelamin A interplay in human fibroblasts.
    Capanni C; Del Coco R; Mattioli E; Camozzi D; Columbaro M; Schena E; Merlini L; Squarzoni S; Maraldi NM; Lattanzi G
    Biol Cell; 2009 Sep; 101(9):541-54. PubMed ID: 19323649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis.
    Greenberg SA; Watts GD; Kimonis VE; Amato AA; Pinkus JL
    Muscle Nerve; 2007 Oct; 36(4):447-54. PubMed ID: 17626287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.